Extracranial Carotid and Vertebral Artery Dissection

DOI: https://doi.org/10.30702/ujcvs/24.32(04)/KM074-133142
Keywords: cervical artery dissection, anticoagulants, antiplatelets, arterial reconstruction, complications, long-term outcomes

Abstract

Cervical artery dissection (CAD) is a rare vascular pathology that causes stroke in 2.0% of cases and is the most common cause of ischemic stroke among young patients. Today the choice of optimal treatment of CAD remains controversial, especially the issue of choosing antiplatelet and anticoagulant therapy, the expediency of endovascular and surgical approaches.

The aim. To analyze the results of management of extracranial carotid and vertebral artery dissection.

Materials and methods. Retrospective and prospective analysis of the results of comprehensive examination and treatment in 40 patients (17 [42.5%] men and 23 [57.5%] women, mean age 48.7 ± 13.4 years) with CAD was performed. Of these, 14 (35.0%) patients underwent surgical management, 26 (65.0%) received conservative treatment.

Results. Etiology of CAD included: atherosclerosis in 13 (32.5%), fibromuscular dysplasia in 12 (30.0%), trauma in 3 (7.5%), and nonspecific aortoarteritis in 1 (2.5%) patient. Spontaneous CAD was observed in 11 (27.5%) patients. The choice of surgical tactics in patients with carotid artery dissection was justified due to lesion of proximal extracranial segment with unstable ulcerative atherosclerotic plaque, critical stenosis, dissecting aneurysm. The choice of optimal anticoagulant and antiplatelet therapy in conservative group was predicted by individual approach, including the risk of bleeding and ischemic stroke. Long-term results were evaluated among 22 patients who received conservative treatment. Complete resolution of dissection was noted in 15 (68.2%), partial in 4 (18.2%), recurrence of dissection in 1 (4.5%) patient. In 9 (40.9%) patients, complete resolution of dissection was observed within 6 months of treatment.

Conclusion. The choice of anticoagulant and antiplatelet therapy of CAD requires an individual approach with evaluation of the risk of bleeding, ischemic stroke, duration of the disease, lumen recanalization, atherosclerotic lesion, patient’s comorbidity. Novel oral anticoagulants and their combination with antiplatelets allow to achieve effective results of treatment of CAD and prevent the recurrence of ischemic events.

References

  1. Yaghi S, Engelter S, Del Brutto VJ, Field TS, Jadhav AP, Kicielinski K, et al.; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Council on Peripheral Vascular Disease. Treatment and Outcomes of Cervical Artery Dissection in Adults: A Scientific Statement From the American Heart Association. Stroke. 2024;55(3):e91-e106. https://doi.org/10.1161/STR.0000000000000457
  2. Goodfriend SD, Tadi P, Koury R. Carotid Artery Dissection. [Updated 2022 Dec 19; cited 2024 Oct 03]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430835/
  3. Zhou B, Hua Z, Li C, Jiao Z, Cao H, Xu P, et al. Classification and management strategy of spontaneous carotid artery dissection. J Vasc Surg. 2024;80(4):1139-1148. https://doi.org/10.1016/j.jvs.2024.05.031
  4. Wu Y, Chen H, Xing S, Tan S, Chen X, Tan Y, et al. Predisposing factors and radiological features in patients with internal carotid artery dissection or vertebral artery dissection. BMC Neurol. 2020;20(1):445. https://doi.org/10.1186/s12883-020-02020-8
  5. Clark M, Unnam S, Ghosh S. A review of carotid and vertebral artery dissection. Br J Hosp Med (Lond). 2022;83(4):1-11. https://doi.org/10.12968/hmed.2021.0421
  6. Mehdi E, Aralasmak A, Toprak H, Yıldız S, Kurtcan S, Kolukisa M, et al. Craniocervical Dissections: Radiologic Findings, Pitfalls, Mimicking Diseases: A Pictorial Review. Curr Med Imaging Rev. 2018;14(2):207-222. https://doi.org/10.2174/1573405613666170403102235
  7. Yun SH,Park JC.Endovascular Stenting for the Treatment of an Initially Asymptomatic Patient with Traumatic Carotid Artery Dissection. Korean J Crit Care Med. 2017;32(3):297-301. https://doi.org/10.4266/kjccm.2017.00010
  8. Buelens T, Scifo L, Schetgen J, Ould Hamou M, Kampouridis S, Willermain F. Internal Carotid Artery Dissection Presenting with Transient or Subclinical Horner Syndrome. Case Rep Ophthalmol. 2024;15(1):29-35. https://doi.org/10.1159/000535475
  9. Sengelhoff C, Nebelsieck J, Nassenstein I, Maintz D, Nabavi DG, Kuhlenbaeumer G, et al. Neurosonographical follow-up in patients with spontaneous cervical artery dissection. Neurol Res. 2008;30(7):687-689. https://doi.org/10.1179/174313208X319080
  10. Janquli M, Selvarajah L, Moloney MA, Kavanagh E, O’Neill DC, Medani M. Long-term outcome of cervical artery dissection. J Vasc Surg. 2023;78(1):158-165. https://doi.org/10.1016/j.jvs.2023.03.020
  11. Ben Hassen W, Machet A, Edjlali-Goujon M, Legrand L, Ladoux A, Mellerio C, et al. Imaging of cervical artery dissection. Diagn Interv Imaging. 2014;95(12):1151-1161. https://doi.org/10.1016/j.diii.2014.10.003
  12. Hakimi R, Sivakumar S. Imaging of Carotid Dissection. Curr Pain Headache Rep. 2019;23(1):2. https://doi.org/10.1007/s11916-019-0741-9
  13. Daou B, Hammer C, Mouchtouris N, Starke RM, Koduri S, Yang S, et al. Anticoagulation vs Antiplatelet Treatment in Patients with Carotid and Vertebral Artery Dissection: A Study of 370 Patients and Literature Review. Neurosurgery. 2017;80(3):368-379. https://doi.org/10.1093/neuros/nyw086
  14. Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364-e467. https://doi.org/10.1161/STR.0000000000000375
  15. Ye SL, Wang C, Wang LL, Xu TZ, Li XQ, Tang T. Oral Anticoagulant and Antiplatelet Therapy for Cervical Artery Dissection: A Meta-Analysis of Clinical Trials. Clin Appl Thromb Hemost. 2021;27:10760296211051708. https://doi.org/10.1177/10760296211051708
  16. Chowdhury MM, Sabbagh CN, Jackson D, Coughlin PA, Ghosh J. Antithrombotic Treatment for Acute Extracranial Carotid Artery Dissections: A Meta-Analysis. Eur J Vasc Endovasc Surg. 2015;50(2):148-156. https://doi.org/10.1016/j.ejvs.2015.04.034
  17. Kennedy F, Lanfranconi S, Hicks C, Reid J, Gompertz P, Price C, et al.; CADISS Investigators. Antiplatelets vs anticoagulation for dissection: CADISS nonrandomized arm and meta-analysis. Neurology. 2012;79(7):686-689. https://doi.org/10.1212/WNL.0b013e318264e36b
  18. Lyrer P, Engelter S. Antithrombotic drugs for carotid artery dissection. Cochrane Database Syst Rev. 2010;(10):CD000255. https://doi.org/10.1002/14651858.CD000255.pub2
  19. Debette S, Mazighi M, Bijlenga P, Pezzini A, Koga M, Bersano A, et al. ESO guideline for the management of extracranial and intracranial artery dissection. Eur Stroke J. 2021;6(3):XXXIX-LXXXVIII. https://doi.org/10.1177/23969873211046475
  20. Markus HS, Levi C, King A, Madigan J, Norris J; Cervical Artery Dissection in Stroke Study (CADISS) Investigators. Antiplatelet Therapy vs Anticoagulation Therapy in Cervical Artery Dissection: The Cervical Artery Dissection in Stroke Study (CADISS) Randomized Clinical Trial Final Results. JAMA Neurol. 2019;76(6):657-664. https://doi.org/10.1001/jamaneurol.2019.0072
  21. Engelter ST, Traenka C, Gensicke H, Schaedelin SA, Luft AR, Simonetti BG, et al.; TREAT-CAD investigators. Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trial. Lancet Neurol. 2021;20(5):341-350. https://doi.org/10.1016/S1474-4422(21)00044-2
  22. Essibayi MA, Lanzino G, Keser Z. Vitamin K antagonist versus novel oral anticoagulants for management of cervical artery dissection: interactive systematic review and meta-analysis. Eur Stroke J. 2022;7(4):349-357. https://doi.org/10.1177/23969873221111051
  23. Yaghi S, Shu L, Mandel D, Leon Guerrero CR, Henninger N, Muppa J, et al. Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection: The STOP-CAD Study. Stroke. 2024;55(4):908-918.
  24. Del Giovane C, Boncoraglio GB, Bertù L, Banzi R, Tramacere I. Antiplatelet drugs for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis. BMC Neurol. 2021;21(1):319. https://doi.org/10.1186/s12883-021-02341-2
  25. Kurre W, Bansemir K, Aguilar Pérez M, Martinez Moreno R, Schmid E, Bäzner H, et al. Endovascular treatment of acute internal carotid artery dissections: technical considerations, clinical and angiographic outcome. Neuroradiology. 2016;58(12):1167-1179. https://doi.org/10.1007/s00234-016-1757-z
  26. Pham MH, Rahme RJ, Arnaout O, Hurley MC, Bernstein RA, Batjer HH, et al. Endovascular Stenting of Extracranial Carotid and Vertebral Artery Dissections: A Systematic Review of the Literature. Neurosurgery. 2011;68(4):856-866. https://doi.org/10.1227/NEU.0b013e318209ce03
  27. Müller BT, Luther B, Hort W, Neumann-Haefelin T, Aulich A, Sandmann W. Surgical treatment of 50 carotid dissections: Indications and results. J Vasc Surg. 2000;31(5):980-988. https://doi.org/10.1067/mva.2000.104586
  28. Lounsbury E, Niznick N, Mallick R, Dewar B, Davis A, Fergusson DA, et al. Recurrence of cervical artery dissection: A systematic review and meta-analysis. Int J Stroke. 2024;19(4):388-396. https://doi.org/10.1177/17474930231201434
Published
2024-12-27
How to Cite
1.
Kobza II, Mota YS. Extracranial Carotid and Vertebral Artery Dissection. ujcvs [Internet]. 2024Dec.27 [cited 2025Jan.21];32(4):133-42. Available from: https://cvs.org.ua/index.php/ujcvs/article/view/696
Issue
Ukrainian Journal of Cardiovascular Surgery Vol 32 No 4 2024
Section
VASCULAR SURGERY